arrow_back Back to App

Sickle Cell Disease Treatment: New Centers, Better Care

This act establishes a program to support individuals with sickle cell disease and similar blood disorders. Specialized treatment centers will be created to provide coordinated medical care, education, and support for patients and their families. The goal is to improve access to treatment and quality of life for those affected, regardless of their location.
Key points
New sickle cell disease treatment centers will be established, offering comprehensive medical care, including psychological and social support.
The program aims to improve access to treatment, including telemedicine and transportation, and to educate patients and medical staff.
A national coordinating center will be created to oversee activities and collect data, helping to monitor and improve care for patients.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_8855
Sponsor: Rep. Lee, Barbara [D-CA-13]
Process start date: 2022-09-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Sickle Cell Disease Treatment Centers Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8855.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-09-15.

What are the main provisions?

Key points include:

  • New sickle cell disease treatment centers will be established, offering comprehensive medical care, including psychological and social support.
  • The program aims to improve access to treatment, including telemedicine and transportation, and to educate patients and medical staff.
  • A national coordinating center will be created to oversee activities and collect data, helping to monitor and improve care for patients.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Lee, Barbara [D-CA-13].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health